ANIXA BIOSCIENCES, INC. Employee Benefits and Share-based Compensation
ANIXA BIOSCIENCES, INC. (ANIX) reported Employee Benefits and Share-based Compensation of $1.04 million for the 3-month period ending 2014-01-31, per its 10-Q filed 2014-03-17.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2014-03-17
- ANIXA BIOSCIENCES, INC. employee benefits and share-based compensation for the quarter ending 2014-01-31 was $1.04M, a 27.47% increase year-over-year.
- ANIXA BIOSCIENCES, INC. employee benefits and share-based compensation for the quarter ending 2013-01-31 was $819.00K.
- ANIXA BIOSCIENCES, INC. employee benefits and share-based compensation for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- ANIXA BIOSCIENCES, INC. employee benefits and share-based compensation for fiscal 2012 was $927.00K.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 12 month | Employee Benefits and Share-based Compensation 12 month as first filed |
|---|---|---|---|
| 2014-01-31 | $1.04M 10-Q · filed 2014-03-17 | ||
| 2013-10-31 | $0.00 10-K/A · filed 2014-01-17 | ||
| 2013-01-31 | $819.00K 10-Q · filed 2014-03-17 | ||
| 2012-10-31 | $927.00K 10-K/A · filed 2014-01-17 | $85.00K 10-K · filed 2013-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |